BRIAN ROSE: Open Payments
NPI 1578079356 · RAEFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,679 in 138 payments from 20 companies in 2025. Trend: 2023 $8,144 · 2024 $31,067 · 2025 $30,679
Speaker / faculty: $17,066Food & beverage: $4,521Honoraria: $4,000Travel & lodging: $3,067Consulting: $2,025
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 50 | $22,779 |
| SCPHARMACEUTICALS INC. | 7 | $4,080 |
| Esperion Therapeutics, Inc. | 3 | $1,040 |
| Actelion Pharmaceuticals US, Inc. | 9 | $521 |
| United Therapeutics Corporation | 13 | $489 |
| AstraZeneca Pharmaceuticals LP | 7 | $233 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $230 |
| Novo Nordisk Inc | 7 | $189 |
| Merck Sharp & Dohme LLC | 11 | $187 |
| Boston Scientific Corporation | 3 | $169 |
Products named: Kerendia, FUROSCIX, NEXLIZET, UPTRAVI, Tyvaso, LifeVest, Adempas, SYMPLICITY G3.
Industry payments across NC — which companies pay providers there.
